All Industry News articles – Page 2
-
NewsCollaboration garners new support to tackle high-value tuberculosis targets
A groundbreaking collaboration will combat global health challenges in tuberculosis through innovative technology.
-
NewsIVI starts technology transfer to Biological E. Limited to manufacture oral cholera vaccine for India and global markets
The International Vaccine Institute (IVI) has announced that it has commenced a technology transfer of simplified Oral Cholera Vaccine (OCV-S) to Biological E. Limited (BE), a leading India-based vaccines and pharmaceutical company.
-
NewsResearchers call for regulation of direct-to-consumer microbiome tests
Scientists argue that direct-to-consumer (DTC) microbiome tests lack analytical and clinical validity and require more federal regulation to prevent consumer harm.
-
NewsAMI unveils plans to launch educational series The Microbiologist Masterclass
Applied Microbiology International has announced it will be launching a new series of educational online content called The Microbiologist Masterclass. AMI will be teaming up with industry partners to present this series of educational assets including webinars, ‘how-to’ guides and the latest product information, plus practical tips and tricks to ...
-
NewsSK bioscience’s typhoid conjugate vaccine achieves WHO prequalification
SK bioscience and the International Vaccine Institute (IVI) announced that the typhoid conjugate vaccine developed by SK bioscience with technology transfer from IVI has achieved the World Health Organization prequalification (PQ).
-
NewsBiotech start-up BugBiome secures investment for research in sustainable pest protection
BugBiome, a biotech harnessing nature’s microbial defences for pest protection to benefit human and planet health, has successfully closed a pre-seed funding round, securing £310k from Cambridge Angels and Discovery Park Ventures.
-
NewsCARB-X funds Visby Medical to develop a portable rapid diagnostic for gonorrhea
Visby Medical aims to improve patients’ health outcomes and increase the lifespan of the last remaining antibiotic for resistant gonorrhea.
-
NewsValneva vaccinates first participant in pediatric trial of single-shot Chikungunya vaccine
Valneva SE has announced that the first participant has been vaccinated in the Phase 2 clinical trial evaluating the safety and immunogenicity in children of two different dose levels of Valneva’s single-shot chikungunya vaccine.
-
NewsNovo Nordisk Foundation partners with CARB-X to fight drug-resistant infections
The Novo Nordisk Foundation is committing up to $25 million to support the early-stage development of innovative tools to prevent, diagnose and treat the most dangerous drug-resistant bacterial infections. The three-year grant will go to the Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X), the leading global non-profit public-private partnership in this ...
-
![RW703786[46]](https://d3rmrttq0bsnxi.cloudfront.net/Pictures/100x67/4/2/2/5422_rw70378646_994081.jpg)
NewsFA Bio secures £5.3m investment from Clean Growth Fund, Pymwymic and Ship2B Ventures
FA Bio, the British bio-tech company, has secured a £5.3 million tranche of investment from three European venture capital investment funds as well as existing shareholders and new private investors.
-
NewsCalibr announces license agreement with Gilead to develop long-acting HIV antiviral agent
Long-acting combination HIV regimens have the potential to transform the future of coordinated HIV clinical care
-
NewsIndustry collaboration funds development of RNA drugs against dengue fever virus
University team use patented nuclear magnetic resonance (NMR)-based screening method to identify small molecules that specifically bind to the viruses’ highly conserved RNA structures and interrupt the viral infection cycle.
-
NewsSimplified formulation of oral cholera vaccine, licensed by Korean regulatory agency
Euvichol-S, a simplified formulation of oral cholera vaccine, has been licensed by Korean regulatory agency, and is expected to alleviate global cholera vaccine shortages.
-
NewsSoil microbiome yields revolutionary new biofungicide
The Boyce Thompson Institute (BTI), a leader in plant science research, has announced that Ascribe Bioscience has partnered with Nutrien Ag Solutions to commercialize two crop protection products containing biofungicide Phytalix®.
-
NewsDenovAI uses artificial intelligence to discover therapeutic antibodies
Kashif Sadiq has founded a start-up – DenovAI – for broader, faster and cheaper antibody discovery using advanced machine learning and computational biophysics.
-
News€20 million EIB venture debt financing to support microbiome research and development
The EIB has signed €20 million in venture debt financing with Belgian microbiome health company The Akkermansia Company to accelerate the R&D and commercial activities around the Akkermansia muciniphila bacterium.
-
![Pioneer Awards - Emmanuel Ladent, Carbios, and Jacques Playe, L'Oreal[88]](https://d3rmrttq0bsnxi.cloudfront.net/Pictures/100x67/7/4/8/4748_pioneerawardsemmanuelladentcarbiosandjacquesplayeloreal88_710603.jpg)
NewsCarbios and L’Oréal win Pioneer Award for world’s first enzymatically recycled cosmetic bottle
The Solar Impulse Foundation has recognised Carbios’ breakthrough innovation and its adoption in 2021 by L’Oréal with the world’s first fully enzymatically recycled plastic cosmetic bottle.
-
NewsIridescentBio bringing virtual high-throughput assays to antibody R&D
IridescentBio is a new techbio start-up that’s bringing creative chemistry, physics know-how and methods to the Biopharma R&D world. The team of four are building computational models in the cloud to provide forecasting superpowers for lab-based research and development of antibody therapeutics. IridescentBio’s modelling framework is already ...
-
NewsSaudi Public Health Authority and BGI Genomics sign MoU to advance public health
BGI Genomics has signed a Memorandum of Understanding (MoU) with the Saudi Public Health Authority (PHA) to inject new impetus into the cause of public health in Saudi Arabia.
-
NewsNew typhoid conjugate vaccine Bio-TCV® approved in Indonesia
Bio Farma’s Bio-TCV® typhoid conjugate vaccine (TCV) has been licensed in Indonesia following marketing approval from Badan Pengawas Obat dan Makanan (BPOM), the national regulatory authority.
